The Regulatory Affairs and Compliance team at Esperion Therapeutics is responsible for ensuring that all drug development and commercialization activities adhere to regulatory standards and guidelines. This team collaborates closely with various departments to navigate the regulatory landscape, manage submissions to health authorities, and address compliance issues, ultimately facilitating the approval and market entry of innovative LDL-C lowering therapies. Their work is crucial for maintaining the integrity and safety of the company’s products while supporting the mission to reduce global cardiovascular disease.
Amy Wilson
Vice President, Chief Complian...
Daniel Gass
Executive Director - Pricing, ...
Dr. Rekha Vemuri
Senior Manager
Jessica Yang Pharmd
Manager, Global Regulatory Aff...
Michelle Bennett
Associate Director, Procuremen...
Pacs Andi Ayes
Senior Director, Market Access...
Philippe Jayat
Global Logistics Manager
Pragna Patel
Senior Director Clinical Opera...
Priya Batheja
Director, Project Leader - Dru...
Satish Nachaegari
Vice President, Global Regulat...
View all